Tausif Butt - 14 Jun 2021 Form 4 Insider Report for ChemoCentryx, Inc.

Role
EVP, Chief Operating Officer
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 19:01:29 UTC
Previous filing
10 May 2021
Next filing
24 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Award +75,000 75,000 14 Jun 2021 Common Stock 75,000 $13.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 14, 2021, and 25% of the total number of shares of common stock subject to the option vests on June 14, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
F2 Not applicable.